Blue Owl Capital Holdings »

Ftac Emerald Acquisition Cor Class A shares owned by Blue Owl Capital Holdings

Quarter-by-quarter ownership of Ftac Emerald Acquisition Cor Class A (FLD) shares owned by Blue Owl Capital Holdings from 13F filings

Historical chart of Blue Owl Capital Holdings investment in Ftac Emerald Acquisition Cor Class A

Tip: Access up to 7 years of quarterly data

All positions including Ftac Emerald Acquisition Cor Class A held by Blue Owl Capital Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ftac Emerald Acquisition Cor Class A by Blue Owl Capital Holdings

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.4M 857k 1.69
2025-06-30 $1.9M 857k 2.24

More positions owned by Blue Owl Capital Holdings

Nuveen Churchill Direct Lend Com Shs (NCDL)
Owl Rock Capital Corporation (OBDC)
Engene Holdings (ENGN)
Larimar Therapeutics (LRMR)
Evercommerce (EVCM)
Holley (HLLY)
Roivant Sciences SHS (ROIV)
Cullinan Oncology (CGEM)
Ultragenyx Pharmaceutical (RARE)
Conduent Incorporate (CNDT)
Sagimet Biosciences Com Ser A (SGMT)
Compass Therapeutics (CMPX)
Dell Technologies CL C (DELL)
Civeo Corp Cda Com New (CVEO)
Context Therapeutics (CNTX)

View all positions for Blue Owl Capital Holdings

Top funds holding Ftac Emerald Acquisition Cor Class A

Vanguard Group
Blue Owl Capital Holdings
Susquehanna International
Geode Capital Management
Baird Financial
Union Square Park Capital Management
UBS Group
Vontobel Holding
Marshall Wace
Cypress Point Wealth Management
Citadel Advisors
Evernest Financial Advisors
Mariner Wealth Advisors
BlackRock
State Street Corporation

View all funds holding Ftac Emerald Acquisition Cor Class A